Ishares Genomics Immunology Etf Price History

IShares Genomics Etf Price History Chart

IShares Genomics December 12, 2024 Etf Price Synopsis

Various analyses of IShares Genomics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell IShares Etf. It can be used to describe the percentage change in the price of IShares Genomics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of IShares Etf. When benchmark price declines in a down market, there may be an uptick in iShares Genomics Immunology Etf price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use IShares Genomics intraday prices and daily technical indicators to check the level of noise trading in iShares Genomics Immunology Etf and then apply it to test your longer-term investment strategies against IShares.

IShares Etf Price History Data

The price series of IShares Genomics for the period between Fri, Sep 13, 2024 and Thu, Dec 12, 2024 has a statistical range of 2.56 with a coefficient of variation of 2.09. Under current investment horizon, the daily prices are spread out with arithmetic mean of 24.37. The median price for the last 90 days is 24.45. The company completed dividends distribution on 16th of December 2019.

IShares Genomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for IShares is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in iShares Genomics Imm will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing IShares Genomics stock prices may prove useful in developing a viable investing in IShares Genomics

IShares Genomics technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.

Predictive indicators are helping investors to find signals for IShares Genomics' price direction in advance. Along with the technical and fundamental analysis of IShares Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of IShares to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Genomics Immunology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

The market value of iShares Genomics Imm is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Genomics' value that differs from its market value or its book value, called intrinsic value, which is IShares Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Genomics' market value can be influenced by many factors that don't directly affect IShares Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between IShares Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.